Jessica Cook

Jessica Cook

Auto-generated profile, based on publicly available information

Jessica Cook

Program in Craniofacial Biology and Department of Orofacial Sciences, University of California, San Francisco, San Francisco, CA 94143, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2017 in Frontiers in Immunology
Verified
Journal Article
Open access
Kawaljit KaurKawaljit Kaur
Kawaljit Kaur
JCJessica Cook
Jessica Cook
SPSo-Hyun Park
So-Hyun Park
PTPaytsar Topchyan
Paytsar Topchyan
AKAnna Kozłowska
Anna Kozłowska
Anahid JewettAnahid Jewett
Anahid Jewett
Natural killer (NK) cells are known to target cancer stem cells and undifferentiated tumors. In this paper, we provide a novel strategy for expanding large numbers of super-charged NK cells with significant potential to lyse and differentiate cancer stem cells, and demonstrate the differences in the dynamics of NK cell expansion between healthy and cancer patients. Decline in cytotoxicity and lower IFN-γ secretion by osteoclast-expanded NK cells from cancer patients correlates with faster expansion of residual contaminating T cells within purified NK cells, whereas healthy donors’ osteoclasts continue expanding super-charged NK cells while limiting T cell expansion for up to 60 days. Similar to patient NK cells, NK cells from tumor-bearing BLT humanized mice promote faster expansion of residual T cells resulting in decreased numbers and function of NK cells, while NK cells from mice with no tumor continue expanding NK cells and retain their cytotoxicity. In addition, dendritic cells in contrast to osteoclasts are found to promote faster expansion of residual T cells within purified NK cells resulting in the decline in NK cell numbers from healthy individuals. Addition of anti-CD3 mAb inhibits T cell proliferation while enhancing NK cell expansion, however, expanding NK cells have lower cytotoxicity but higher secretion of IFN-. Expansion and functional activation of super-charged NK cells by osteoclasts is dependent on IL-12 and IL-15. Thus, in this report we not only provide a novel strategy to expand super-charged NK cells, but also demonstrate that rapid and sustained expansion of residual T cells within the purified NK cells during expansion with dendritic cells or osteoclasts could be a potential mechanism by which the numbers and function of NK cells decline in cancer patients and in BLT humanized mice.

4 December 2017 in Frontiers in Immunology
Verified
Journal Article
Open access
Kawaljit KaurKawaljit Kaur
Kawaljit Kaur
HCHui-Hua Chang
Hui-Hua Chang
JCJessica Cook
Jessica Cook
GEGuido Eibl
Guido Eibl
Anahid JewettAnahid Jewett
Anahid Jewett
The aim of our studies is to determine the dynamics of natural killer (NK) cell modulation in gingivae in precancerous and cancerous stages of pancreatic and oral cancers in P48+/Cre;LSL-KRASG12D (KC) mice carrying a pancreas-specific oncogenic Kras mutation and BLT-humanized mice. Wild type and KC mice fed with control diet (CD) or high-fat calorie diet (HFCD), and the pancreatic and oral tumor-bearing humanized BLT (hu-BLT) mice were used to determine precancerous and cancer induced changes in numbers and function of gingival NK cells. Increased numbers of PanIN lesions and the greatest score of inflammation in pancreas of KC mice fed with CD and HFCD co-related with significant decline in percentages of circulating and gingival NK cells, lack of DX5+ NK expansion and increased secretion of IFN-γ and IL-6 after culture. At the malignant stage of pancreatic cancer, hu-BLT tumor-bearing mice had the lowest secretion of IFN-γ from cells dissociated from the gingival tissues as compared to those from non-tumor-bearing mice. Injection of NK cells into tumor-bearing mice increased IFN-γ secretion, and the secretion was similar or higher than those obtained by gingival cells from non-tumor-bearing hu-BLT control mice. The highest increase in IFN-γ secretion was observed when tumor-bearing mice were fed with AJ2 probiotic bacteria and injected with the NK cells. Along with an increase in secretion of IFN-γ, injection of NK cells in the presence and absence of feeding with AJ2 in pancreatic tumor-bearing mice increased percentages of CD45+ and CD3+ T cells in oral gingival cells. Similar results were observed with oral tumors. In conclusion, these results indicated that oral cavity may mirror systemic disease and provide a rationale for why cancer patients may be prone to suffer from diverse oral pathologies.

2 July 2025 in Science Translational Medicine
Verified
Journal Article
Closed access
MGMichelle Griffin
Michelle Griffin
JCJessica Cook
Jessica Cook
AMAnnah Morgan
Annah Morgan
DBDario Boffelli
Dario Boffelli
MDMauricio Downer
Mauricio Downer
Michael T. LongakerMichael T. Longaker
Michael T. Longaker
Rapid and scarless wound repair is a hallmark of the oral mucosa, yet the cellular and molecular mechanisms that enable this regeneration remain unclear. By comparing populations of murine oral mucosal fibroblasts (OMFs) and facial skin fibroblasts (FSFs), we have identified mechanisms that facilitate regeneration over fibrosis. We found that OMFs used growth arrest specific–6 (GAS6)–angiotoxin receptor–like (AXL) signaling to suppress fibrosis-related mechanosignaling through focal adhesion kinase (FAK) in vitro. Inhibition or knockdown of AXL in the murine oral mucosa resulted in fibrotic wounds and increased activation of FAK. Stimulation of AXL by exogenous GAS6 in the murine facial skin yielded wounds that healed regeneratively as assessed by collagen deposition and organization. Rare human oral scars that resulted from repetitive injury showed decreased expression of GAS6 and AXL and increased FAK. Activating AXL by exogenous GAS6 in repetitively injured mouse oral tissue resulted in better wound healing outcomes and reduced scarring. Altogether, we show that AXL signaling is necessary for murine regenerative wound healing in the oral mucosa and sufficient to limit facial skin fibrosis.